Changes to Cartilage Linked to Bone Cancer Offers a Possible New Diagnostic Approach, Wellcome Trust Sanger Institute Study

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

For the first time, researchers from The Wellcome Trust Sanger Institute, the Royal National Orthopaedic Hospital and UCL Cancer Institute, have linked a gene central to the production of cartilage, COL2A1, to the development of a common type of bone cancer. Their discovery may act as an important way to diagnose this type of cancer in the future, improving patient care.

Hey, check out all the engineering jobs. Post your resume today!

Back to news